
Breast Imaging Market Forecast to 2033 : Type (Mammography, Breast Ultrasound, Breast MRI, Breast Tomosynthesis, Molecular Breast Imaging, Breast Thermography, Positron Emission Mammography, Optical Imaging, Elastography, Others), Product (Imaging Syst
Description
Breast Imaging Market Forecast to 2033 : Type (Mammography, Breast Ultrasound, Breast MRI, Breast Tomosynthesis, Molecular Breast Imaging, Breast Thermography, Positron Emission Mammography, Optical Imaging, Elastography, Others), Product (Imaging Systems, Biopsy Systems, Software, Accessories, Others), Services (Screening, Diagnostic, Consultation, Maintenance, Training, Others), Technology (D Imaging, D Imaging, D Imaging, Digital Imaging, Analog Imaging, Hybrid Imaging, Others), Application (Cancer Detection, Pre-Surgical Planning, Routine Screening, Research, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Specialty Clinics, Research Institutes, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa, Others)
The breast imaging market encompasses a range of diagnostic and screening technologies designed to detect and evaluate breast diseases, particularly breast cancer. This market includes various imaging modalities such as mammography, ultrasound, magnetic resonance imaging (MRI), and nuclear imaging techniques. These technologies are utilized not only for early detection and diagnosis but also for monitoring treatment efficacy and guiding biopsy procedures. The market is driven by advancements in imaging technology, increasing awareness of breast cancer, and the rising prevalence of the disease globally.
The breast imaging market size was USD 4.3 billion in 2023 and is anticipated to reach USD 7.2 billion in 2033, growing at a rate of 5.3% from 2024 to 2033.
One of the primary drivers of the breast imaging market is the growing emphasis on early detection and preventive healthcare. Governments and healthcare organizations worldwide are investing in breast cancer screening programs, leading to higher adoption rates of advanced imaging technologies. Additionally, the development of novel imaging techniques, such as 3D mammography (tomosynthesis) and molecular breast imaging (MBI), is expanding the market's scope. These innovations offer improved accuracy, reduced false positives, and enhanced patient comfort, thereby fostering market growth. The breast imaging market is poised for significant expansion as technological advancements continue to improve diagnostic capabilities and patient outcomes.
Key Trends:
- Advancements in AI and Machine Learning: Integration of AI for enhanced image analysis and diagnostic accuracy in breast imaging technologies.
- Rise of 3D Mammography: Increased adoption of 3D mammography (tomosynthesis) for better detection rates and reduced false positives.
- Growing Use of Ultrasound: Expanded use of breast ultrasound, particularly automated breast ultrasound systems (ABUS), for supplemental screening.
- Personalized Screening Programs: Development of personalized breast cancer screening programs based on individual risk factors and genetic predispositions.
- Telemedicine Integration: Incorporation of telemedicine platforms for remote consultation and second opinions, improving access to breast imaging services..
- Technological Advancements: Continuous innovation in imaging technologies, such as 3D mammography and AI-enhanced diagnostics, enhances detection accuracy and efficiency.
- Rising Prevalence of Breast Cancer: Increasing incidence rates globally drive the demand for early detection and regular screening, boosting market growth.
- Government Initiatives and Funding: Supportive policies and financial incentives from governments worldwide encourage the adoption of advanced breast imaging solutions.
- Growing Awareness and Education: Enhanced awareness campaigns and educational programs about breast cancer screening contribute to higher adoption rates of imaging technologies.
- Aging Population: The growing elderly population, which is more susceptible to breast cancer, propels the need for regular and advanced imaging solutions.
- High Cost of Advanced Imaging Technologies: The substantial investment required for state-of-the-art imaging equipment can be a significant barrier for healthcare providers, particularly in developing regions.
- Regulatory and Compliance Challenges: Stringent regulatory requirements and the need for compliance with various international standards can delay product launches and increase operational costs.
- Limited Access in Low-Income Regions: Inadequate healthcare infrastructure and limited financial resources in low-income regions restrict the adoption of advanced breast imaging technologies.
- Shortage of Skilled Radiologists: The growing demand for breast imaging procedures exacerbates the shortage of trained radiologists, which can impact the timely and accurate diagnosis of breast cancer.
- Technological Limitations: Despite advancements, certain imaging technologies still face limitations in terms of sensitivity and specificity, which can hinder the early detection and accurate diagnosis of breast cancer.
Type (Mammography, Breast Ultrasound, Breast MRI, Breast Tomosynthesis, Molecular Breast Imaging, Breast Thermography, Positron Emission Mammography, Optical Imaging, Elastography, Others), Product (Imaging Systems, Biopsy Systems, Software, Accessories, Others), Services (Screening, Diagnostic, Consultation, Maintenance, Training, Others), Technology (D Imaging, D Imaging, D Imaging, Digital Imaging, Analog Imaging, Hybrid Imaging, Others), Application (Cancer Detection, Pre-Surgical Planning, Routine Screening, Research, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Specialty Clinics, Research Institutes, Others), Region
Key Players:
The Breast Imaging Market includes players such as Hologic, GE Healthcare, Siemens Healthineers, Fujifilm Holdings, Philips Healthcare, Canon Medical Systems, Carestream Health, Hitachi Medical Systems, Planmed, Toshiba Medical Systems, Konica Minolta, Agfa-Gevaert, Delphinus Medical Technologies, SonoCiné, SuperSonic Imagine, Volpara Solutions, QT Ultrasound, KUB Technologies, Dilon Technologies, Micrima, CureMetrix, iCAD, ScreenPoint Medical, Seno Medical Instruments, Zebra Medical Vision, Therapixel, Metis Health Analytics, Imago Systems, Volpara Health, Three Palm Software, QView Medical, NueMD, Candelis, Xoran Technologies, DR Systems, TeraRecon, Median Technologies, Medsight Technologies, VuComp, ClariPi, among others.
Value Chain Analysis:
The value chain analysis for the Breast Imaging Market encompasses several critical stages, each contributing to the overall efficiency and effectiveness of the market operations. Below is a detailed examination of each stage:
- Raw Material Procurement: Identify sources of raw materials essential for breast imaging technologies, such as high-quality semiconductors, specialized plastics, and advanced imaging components. Assess the availability, quality, and sustainability of these materials. Understanding market dynamics, pricing trends, and potential risks associated with sourcing materials is crucial to ensure a steady and cost-effective supply chain.
- R&D: Research and Development in the breast imaging market involves extensive market analysis, trend forecasting, and feasibility studies. This stage focuses on conducting experiments to develop innovative imaging technologies, such as 3D mammography, digital breast tomosynthesis, and MRI advancements. Collaborations with academic institutions, continuous innovation, and intellectual property management are pivotal for staying ahead in the competitive landscape.
- Product Approval: This stage requires a thorough understanding of legal requirements, industry regulations, and certification processes. It involves rigorous testing of breast imaging products for safety, efficacy, and environmental impact. Navigating the regulatory landscape, obtaining necessary approvals from bodies like the FDA, and ensuring compliance with international standards are critical to bringing new products to market successfully.
- Large Scale Manufacturing: Optimizing production processes, improving efficiency, and reducing costs are the primary objectives in this stage. It involves process engineering, automation technologies, and supply chain management to enhance productivity and quality. Ensuring scalability, maintaining high standards of quality control, and implementing lean manufacturing practices are essential to meet market demand effectively.
- Sales and Marketing: Understanding customer needs, market trends, and the competitive landscape is vital in this stage. It involves market segmentation, consumer behavior analysis, and branding strategies to position breast imaging products effectively. Developing strong sales channels, leveraging digital marketing, and building relationships with healthcare providers and institutions are key to driving market penetration and growth.
- Estimates and forecast the overall market size for the total market, across type, application, and region
- Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
- Identify factors influencing market growth and challenges, opportunities, drivers, and restraints
- Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
- Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
- Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
- To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements
- Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
350 Pages
- Chapter 1: Breast Imaging Market Overview
- 1.1 Objectives of the Study
- 1.2 Breast Imaging Market Definition and Scope of the Report
- 1.3 Report Limitations
- 1.4 Years & Currency Considered in the Study
- 1.5 Research Methodologies
- 1.5.1 Secondary Research
- 1.5.2 Primary Research
- 1.5.3 Market Size Estimation: Top-Down Approach
- 1.5.4 Market Size Estimation: Bottom-Up Approach
- 1.5.5 Data Triangulation and Validation
- Chapter 2: Executive Summary
- 2.1 Summary
- 2.2 Key Opinion Leaders
- 2.3. Key Highlights of the Market, by North America
- 2.4. Key Highlights of the Market, by Europe
- 2.5. Key Highlights of the Market, by Asia-Pacific
- 2.6. Key Highlights of the Market, by Latin America
- 2.7. Key Highlights of the Market, by Middle East
- 2.8. Key Highlights of the Market, by Africa
- Chapter 3: Premium Insights on the Market
- 3.1 Market Attractiveness Analysis, by Region
- 3.2. Market Attractiveness Analysis, by North America
- 3.3. Market Attractiveness Analysis, by Europe
- 3.4. Market Attractiveness Analysis, by Asia-Pacific
- 3.5. Market Attractiveness Analysis, by Latin America
- 3.6. Market Attractiveness Analysis, by Middle East
- 3.7. Market Attractiveness Analysis, by Africa
- Chapter 4: Breast Imaging Market Outlook
- 4.1 Breast Imaging Market Segmentation
- 4.2 Market Dynamics
- 4.2.1 Market Drivers
- 4.2.1.1 Driver
- 4.2.1.2 Driver
- 4.2.2 Market Trends
- 4.2.2.1 Trend
- 4.2.2.2 Trend
- 4.2.3 Market Restraints
- 4.2.3.1 Restraint
- 4.2.3.2 Restraint
- 4.2.4 Market Opportunities
- 4.2.4.1 Opportunity
- 4.2.4.2 Opportunity
- 4.3 Porter’s Five Forces Analysis
- 4.3.1 Threat of New Entrants
- 4.3.2 Threat of Substitutes
- 4.3.3 Bargaining Power of Buyers
- 4.3.4 Bargaining Power of Supplier
- 4.3.5 Competitive Rivalry
- 4.4 PESTLE Analysis
- 4.5 Value Chain Analysis
- 4.6 4Ps Model
- 4.7 ANSOFF Matrix
- Chapter 5: Market Strategy
- 5.1 Parent Market Analysis
- 5.2 Supply-Demand Analysis
- 5.3 Consumer Buying Interest
- 5.4 Case Study Analysis
- 5.5 Pricing Analysis
- 5.6 Regulatory Landscape
- 5.7 Supply Chain Analysis
- 5.8 Competition Product Analysis
- 5.9 Recent Developments
- Chapter 6: Breast Imaging Market Size
- 6.1 Breast Imaging Market Size, by Value
- 6.2 Breast Imaging Market Size, by Volume
- Chapter 7: Breast Imaging Market, by Region
- 7.1 Overview
- 7.2 North America
- 7.2.1 United States
- 7.2.1.1 Key Market Trends & Opportunity Analysis
- 7.2.1.2 Market Size and Forecast
- 7.2.2 Canada
- 7.2.2.1 Key Market Trends & Opportunity Analysis
- 7.2.2.2 Market Size and Forecast
- Chapter 8: Competitive Landscape
- 8.1 Overview
- 8.2 Market Share Analysis
- 8.3 Key Player Positioning
- 8.4 Competitive Leadership Mapping
- 8.4.1 Star Players
- 8.4.2 Innovators
- 8.4.3 Emerging Players
- 8.5 Vendor Benchmarking
- 8.6 Developmental Strategy Benchmarking
- 8.6.1 New Product Developments
- 8.6.2 Product Launches
- 8.6.3 Business Expansions
- 8.6.4 Partnerships, Joint Ventures, and Collaborations
- 8.6.5 Mergers and Acquisitions
- Chapter 9: Company Profiles
- 9.1 Hologic
- 9.1.1 Company Overview
- 9.1.2 Company Snapshot
- 9.1.3 Business Segments
- 9.1.4 Business Performance
- 9.1.5 Product Offerings
- 9.1.6 Key Developmental Strategies
- 9.1.7 SWOT Analysis
- 9.2 GE Healthcare
- 9.2.1 Company Overview
- 9.2.2 Company Snapshot
- 9.2.3 Business Segments
- 9.2.4 Business Performance
- 9.2.5 Product Offerings
- 9.2.6 Key Developmental Strategies
- 9.2.7 SWOT Analysis
- 9.3 Siemens Healthineers
- 9.3.1 Company Overview
- 9.3.2 Company Snapshot
- 9.3.3 Business Segments
- 9.3.4 Business Performance
- 9.3.5 Product Offerings
- 9.3.6 Key Developmental Strategies
- 9.3.7 SWOT Analysis
- 9.4 Fujifilm Holdings
- 9.4.1 Company Overview
- 9.4.2 Company Snapshot
- 9.4.3 Business Segments
- 9.4.4 Business Performance
- 9.4.5 Product Offerings
- 9.4.6 Key Developmental Strategies
- 9.4.7 SWOT Analysis
- 9.5 Philips Healthcare
- 9.5.1 Company Overview
- 9.5.2 Company Snapshot
- 9.5.3 Business Segments
- 9.5.4 Business Performance
- 9.5.5 Product Offerings
- 9.5.6 Key Developmental Strategies
- 9.5.7 SWOT Analysis
- 9.6 Canon Medical Systems
- 9.6.1 Company Overview
- 9.6.2 Company Snapshot
- 9.6.3 Business Segments
- 9.6.4 Business Performance
- 9.6.5 Product Offerings
- 9.6.6 Key Developmental Strategies
- 9.6.7 SWOT Analysis
- 9.7 Carestream Health
- 9.7.1 Company Overview
- 9.7.2 Company Snapshot
- 9.7.3 Business Segments
- 9.7.4 Business Performance
- 9.7.5 Product Offerings
- 9.7.6 Key Developmental Strategies
- 9.7.7 SWOT Analysis
- 9.8 Hitachi Medical Systems
- 9.8.1 Company Overview
- 9.8.2 Company Snapshot
- 9.8.3 Business Segments
- 9.8.4 Business Performance
- 9.8.5 Product Offerings
- 9.8.6 Key Developmental Strategies
- 9.8.7 SWOT Analysis
- 9.9 Planmed
- 9.9.1 Company Overview
- 9.9.2 Company Snapshot
- 9.9.3 Business Segments
- 9.9.4 Business Performance
- 9.9.5 Product Offerings
- 9.9.6 Key Developmental Strategies
- 9.9.7 SWOT Analysis
- 9.10 Toshiba Medical Systems
- 9.10.1 Company Overview
- 9.10.2 Company Snapshot
- 9.10.3 Business Segments
- 9.10.4 Business Performance
- 9.10.5 Product Offerings
- 9.10.6 Key Developmental Strategies
- 9.10.7 SWOT Analysis
- 9.11 Konica Minolta
- 9.11.1 Company Overview
- 9.11.2 Company Snapshot
- 9.11.3 Business Segments
- 9.11.4 Business Performance
- 9.11.5 Product Offerings
- 9.11.6 Key Developmental Strategies
- 9.11.7 SWOT Analysis
- 9.12 Agfa-Gevaert
- 9.12.1 Company Overview
- 9.12.2 Company Snapshot
- 9.12.3 Business Segments
- 9.12.4 Business Performance
- 9.12.5 Product Offerings
- 9.12.6 Key Developmental Strategies
- 9.12.7 SWOT Analysis
- 9.13 Delphinus Medical Technologies
- 9.13.1 Company Overview
- 9.13.2 Company Snapshot
- 9.13.3 Business Segments
- 9.13.4 Business Performance
- 9.13.5 Product Offerings
- 9.13.6 Key Developmental Strategies
- 9.13.7 SWOT Analysis
- 9.14 SonoCiné
- 9.14.1 Company Overview
- 9.14.2 Company Snapshot
- 9.14.3 Business Segments
- 9.14.4 Business Performance
- 9.14.5 Product Offerings
- 9.14.6 Key Developmental Strategies
- 9.14.7 SWOT Analysis
- 9.15 SuperSonic Imagine
- 9.15.1 Company Overview
- 9.15.2 Company Snapshot
- 9.15.3 Business Segments
- 9.15.4 Business Performance
- 9.15.5 Product Offerings
- 9.15.6 Key Developmental Strategies
- 9.15.7 SWOT Analysis
- 9.16 Volpara Solutions
- 9.16.1 Company Overview
- 9.16.2 Company Snapshot
- 9.16.3 Business Segments
- 9.16.4 Business Performance
- 9.16.5 Product Offerings
- 9.16.6 Key Developmental Strategies
- 9.16.7 SWOT Analysis
- 9.17 QT Ultrasound
- 9.17.1 Company Overview
- 9.17.2 Company Snapshot
- 9.17.3 Business Segments
- 9.17.4 Business Performance
- 9.17.5 Product Offerings
- 9.17.6 Key Developmental Strategies
- 9.17.7 SWOT Analysis
- 9.18 KUB Technologies
- 9.18.1 Company Overview
- 9.18.2 Company Snapshot
- 9.18.3 Business Segments
- 9.18.4 Business Performance
- 9.18.5 Product Offerings
- 9.18.6 Key Developmental Strategies
- 9.18.7 SWOT Analysis
- 9.19 Dilon Technologies
- 9.19.1 Company Overview
- 9.19.2 Company Snapshot
- 9.19.3 Business Segments
- 9.19.4 Business Performance
- 9.19.5 Product Offerings
- 9.19.6 Key Developmental Strategies
- 9.19.7 SWOT Analysis
- 9.20 Micrima
- 9.20.1 Company Overview
- 9.20.2 Company Snapshot
- 9.20.3 Business Segments
- 9.20.4 Business Performance
- 9.20.5 Product Offerings
- 9.20.6 Key Developmental Strategies
- 9.20.7 SWOT Analysis
- 9.21 CureMetrix
- 9.21.1 Company Overview
- 9.21.2 Company Snapshot
- 9.21.3 Business Segments
- 9.21.4 Business Performance
- 9.21.5 Product Offerings
- 9.21.6 Key Developmental Strategies
- 9.21.7 SWOT Analysis
- 9.22 iCAD
- 9.22.1 Company Overview
- 9.22.2 Company Snapshot
- 9.22.3 Business Segments
- 9.22.4 Business Performance
- 9.22.5 Product Offerings
- 9.22.6 Key Developmental Strategies
- 9.22.7 SWOT Analysis
- 9.23 ScreenPoint Medical
- 9.23.1 Company Overview
- 9.23.2 Company Snapshot
- 9.23.3 Business Segments
- 9.23.4 Business Performance
- 9.23.5 Product Offerings
- 9.23.6 Key Developmental Strategies
- 9.23.7 SWOT Analysis
- 9.24 Seno Medical Instruments
- 9.24.1 Company Overview
- 9.24.2 Company Snapshot
- 9.24.3 Business Segments
- 9.24.4 Business Performance
- 9.24.5 Product Offerings
- 9.24.6 Key Developmental Strategies
- 9.24.7 SWOT Analysis
- 9.25 Zebra Medical Vision
- 9.25.1 Company Overview
- 9.25.2 Company Snapshot
- 9.25.3 Business Segments
- 9.25.4 Business Performance
- 9.25.5 Product Offerings
- 9.25.6 Key Developmental Strategies
- 9.25.7 SWOT Analysis
- 9.26 Therapixel
- 9.26.1 Company Overview
- 9.26.2 Company Snapshot
- 9.26.3 Business Segments
- 9.26.4 Business Performance
- 9.26.5 Product Offerings
- 9.26.6 Key Developmental Strategies
- 9.26.7 SWOT Analysis
- 9.27 Metis Health Analytics
- 9.27.1 Company Overview
- 9.27.2 Company Snapshot
- 9.27.3 Business Segments
- 9.27.4 Business Performance
- 9.27.5 Product Offerings
- 9.27.6 Key Developmental Strategies
- 9.27.7 SWOT Analysis
- 9.28 Imago Systems
- 9.28.1 Company Overview
- 9.28.2 Company Snapshot
- 9.28.3 Business Segments
- 9.28.4 Business Performance
- 9.28.5 Product Offerings
- 9.28.6 Key Developmental Strategies
- 9.28.7 SWOT Analysis
- 9.29 Volpara Health
- 9.29.1 Company Overview
- 9.29.2 Company Snapshot
- 9.29.3 Business Segments
- 9.29.4 Business Performance
- 9.29.5 Product Offerings
- 9.29.6 Key Developmental Strategies
- 9.29.7 SWOT Analysis
- 9.30 Three Palm Software
- 9.30.1 Company Overview
- 9.30.2 Company Snapshot
- 9.30.3 Business Segments
- 9.30.4 Business Performance
- 9.30.5 Product Offerings
- 9.30.6 Key Developmental Strategies
- 9.30.7 SWOT Analysis
- 9.31 QView Medical
- 9.31.1 Company Overview
- 9.31.2 Company Snapshot
- 9.31.3 Business Segments
- 9.31.4 Business Performance
- 9.31.5 Product Offerings
- 9.31.6 Key Developmental Strategies
- 9.31.7 SWOT Analysis
- 9.32 NueMD
- 9.32.1 Company Overview
- 9.32.2 Company Snapshot
- 9.32.3 Business Segments
- 9.32.4 Business Performance
- 9.32.5 Product Offerings
- 9.32.6 Key Developmental Strategies
- 9.32.7 SWOT Analysis
- 9.33 Candelis
- 9.33.1 Company Overview
- 9.33.2 Company Snapshot
- 9.33.3 Business Segments
- 9.33.4 Business Performance
- 9.33.5 Product Offerings
- 9.33.6 Key Developmental Strategies
- 9.33.7 SWOT Analysis
- 9.34 Xoran Technologies
- 9.34.1 Company Overview
- 9.34.2 Company Snapshot
- 9.34.3 Business Segments
- 9.34.4 Business Performance
- 9.34.5 Product Offerings
- 9.34.6 Key Developmental Strategies
- 9.34.7 SWOT Analysis
- 9.35 DR Systems
- 9.35.1 Company Overview
- 9.35.2 Company Snapshot
- 9.35.3 Business Segments
- 9.35.4 Business Performance
- 9.35.5 Product Offerings
- 9.35.6 Key Developmental Strategies
- 9.35.7 SWOT Analysis
- 9.36 TeraRecon
- 9.36.1 Company Overview
- 9.36.2 Company Snapshot
- 9.36.3 Business Segments
- 9.36.4 Business Performance
- 9.36.5 Product Offerings
- 9.36.6 Key Developmental Strategies
- 9.36.7 SWOT Analysis
- 9.37 Median Technologies
- 9.37.1 Company Overview
- 9.37.2 Company Snapshot
- 9.37.3 Business Segments
- 9.37.4 Business Performance
- 9.37.5 Product Offerings
- 9.37.6 Key Developmental Strategies
- 9.37.7 SWOT Analysis
- 9.38 Medsight Technologies
- 9.38.1 Company Overview
- 9.38.2 Company Snapshot
- 9.38.3 Business Segments
- 9.38.4 Business Performance
- 9.38.5 Product Offerings
- 9.38.6 Key Developmental Strategies
- 9.38.7 SWOT Analysis
- 9.39 VuComp
- 9.39.1 Company Overview
- 9.39.2 Company Snapshot
- 9.39.3 Business Segments
- 9.39.4 Business Performance
- 9.39.5 Product Offerings
- 9.39.6 Key Developmental Strategies
- 9.39.7 SWOT Analysis
- 9.40 ClariPi
- 9.40.1 Company Overview
- 9.40.2 Company Snapshot
- 9.40.3 Business Segments
- 9.40.4 Business Performance
- 9.40.5 Product Offerings
- 9.40.6 Key Developmental Strategies
- 9.40.7 SWOT Analysis
- 9.2 Europe
- 9.2.1 United Kingdom
- 9.2.1.1 Key Market Trends & Opportunity Analysis
- 9.2.1.2 Market Size and Forecast
- 9.2.2 Germany
- 9.2.2.1 Key Market Trends & Opportunity Analysis
- 9.2.2.2 Market Size and Forecast
- 9.2.3 France
- 9.2.3.1 Key Market Trends & Opportunity Analysis
- 9.2.3.2 Market Size and Forecast
- 9.2.4 Spain
- 9.2.4.1 Key Market Trends & Opportunity Analysis
- 9.2.4.2 Market Size and Forecast
- 9.2.5 Italy
- 9.2.5.1 Key Market Trends & Opportunity Analysis
- 9.2.5.2 Market Size and Forecast
- 9.2.6 Netherlands
- 9.2.6.1 Key Market Trends & Opportunity Analysis
- 9.2.6.2 Market Size and Forecast
- 9.2.7 Sweden
- 9.2.7.1 Key Market Trends & Opportunity Analysis
- 9.2.7.2 Market Size and Forecast
- 9.2.8 Switzerland
- 9.2.8.1 Key Market Trends & Opportunity Analysis
- 9.2.8.2 Market Size and Forecast
- 9.2.9 Denmark
- 9.2.9.1 Key Market Trends & Opportunity Analysis
- 9.2.9.2 Market Size and Forecast
- 9.2.10 Finland
- 9.2.10.1 Key Market Trends & Opportunity Analysis
- 9.2.10.2 Market Size and Forecast
- 9.2.11 Russia
- 9.2.11.1 Key Market Trends & Opportunity Analysis
- 9.2.11.2 Market Size and Forecast
- 9.2.12 Rest of Europe
- 9.2.12.1 Key Market Trends & Opportunity Analysis
- 9.2.12.2 Market Size and Forecast
- Chapter 10: Competitive Landscape
- 10.1 Overview
- 10.2 Market Share Analysis
- 10.3 Key Player Positioning
- 10.4 Competitive Leadership Mapping
- 10.4.1 Star Players
- 10.4.2 Innovators
- 10.4.3 Emerging Players
- 10.5 Vendor Benchmarking
- 10.6 Developmental Strategy Benchmarking
- 10.6.1 New Product Developments
- 10.6.2 Product Launches
- 10.6.3 Business Expansions
- 10.6.4 Partnerships, Joint Ventures, and Collaborations
- 10.6.5 Mergers and Acquisitions
- Chapter 11: Company Profiles
- 11.1 Hologic
- 11.1.1 Company Overview
- 11.1.2 Company Snapshot
- 11.1.3 Business Segments
- 11.1.4 Business Performance
- 11.1.5 Product Offerings
- 11.1.6 Key Developmental Strategies
- 11.1.7 SWOT Analysis
- 11.2 GE Healthcare
- 11.2.1 Company Overview
- 11.2.2 Company Snapshot
- 11.2.3 Business Segments
- 11.2.4 Business Performance
- 11.2.5 Product Offerings
- 11.2.6 Key Developmental Strategies
- 11.2.7 SWOT Analysis
- 11.3 Siemens Healthineers
- 11.3.1 Company Overview
- 11.3.2 Company Snapshot
- 11.3.3 Business Segments
- 11.3.4 Business Performance
- 11.3.5 Product Offerings
- 11.3.6 Key Developmental Strategies
- 11.3.7 SWOT Analysis
- 11.4 Fujifilm Holdings
- 11.4.1 Company Overview
- 11.4.2 Company Snapshot
- 11.4.3 Business Segments
- 11.4.4 Business Performance
- 11.4.5 Product Offerings
- 11.4.6 Key Developmental Strategies
- 11.4.7 SWOT Analysis
- 11.5 Philips Healthcare
- 11.5.1 Company Overview
- 11.5.2 Company Snapshot
- 11.5.3 Business Segments
- 11.5.4 Business Performance
- 11.5.5 Product Offerings
- 11.5.6 Key Developmental Strategies
- 11.5.7 SWOT Analysis
- 11.6 Canon Medical Systems
- 11.6.1 Company Overview
- 11.6.2 Company Snapshot
- 11.6.3 Business Segments
- 11.6.4 Business Performance
- 11.6.5 Product Offerings
- 11.6.6 Key Developmental Strategies
- 11.6.7 SWOT Analysis
- 11.7 Carestream Health
- 11.7.1 Company Overview
- 11.7.2 Company Snapshot
- 11.7.3 Business Segments
- 11.7.4 Business Performance
- 11.7.5 Product Offerings
- 11.7.6 Key Developmental Strategies
- 11.7.7 SWOT Analysis
- 11.8 Hitachi Medical Systems
- 11.8.1 Company Overview
- 11.8.2 Company Snapshot
- 11.8.3 Business Segments
- 11.8.4 Business Performance
- 11.8.5 Product Offerings
- 11.8.6 Key Developmental Strategies
- 11.8.7 SWOT Analysis
- 11.9 Planmed
- 11.9.1 Company Overview
- 11.9.2 Company Snapshot
- 11.9.3 Business Segments
- 11.9.4 Business Performance
- 11.9.5 Product Offerings
- 11.9.6 Key Developmental Strategies
- 11.9.7 SWOT Analysis
- 11.10 Toshiba Medical Systems
- 11.10.1 Company Overview
- 11.10.2 Company Snapshot
- 11.10.3 Business Segments
- 11.10.4 Business Performance
- 11.10.5 Product Offerings
- 11.10.6 Key Developmental Strategies
- 11.10.7 SWOT Analysis
- 11.11 Konica Minolta
- 11.11.1 Company Overview
- 11.11.2 Company Snapshot
- 11.11.3 Business Segments
- 11.11.4 Business Performance
- 11.11.5 Product Offerings
- 11.11.6 Key Developmental Strategies
- 11.11.7 SWOT Analysis
- 11.12 Agfa-Gevaert
- 11.12.1 Company Overview
- 11.12.2 Company Snapshot
- 11.12.3 Business Segments
- 11.12.4 Business Performance
- 11.12.5 Product Offerings
- 11.12.6 Key Developmental Strategies
- 11.12.7 SWOT Analysis
- 11.13 Delphinus Medical Technologies
- 11.13.1 Company Overview
- 11.13.2 Company Snapshot
- 11.13.3 Business Segments
- 11.13.4 Business Performance
- 11.13.5 Product Offerings
- 11.13.6 Key Developmental Strategies
- 11.13.7 SWOT Analysis
- 11.14 SonoCiné
- 11.14.1 Company Overview
- 11.14.2 Company Snapshot
- 11.14.3 Business Segments
- 11.14.4 Business Performance
- 11.14.5 Product Offerings
- 11.14.6 Key Developmental Strategies
- 11.14.7 SWOT Analysis
- 11.15 SuperSonic Imagine
- 11.15.1 Company Overview
- 11.15.2 Company Snapshot
- 11.15.3 Business Segments
- 11.15.4 Business Performance
- 11.15.5 Product Offerings
- 11.15.6 Key Developmental Strategies
- 11.15.7 SWOT Analysis
- 11.16 Volpara Solutions
- 11.16.1 Company Overview
- 11.16.2 Company Snapshot
- 11.16.3 Business Segments
- 11.16.4 Business Performance
- 11.16.5 Product Offerings
- 11.16.6 Key Developmental Strategies
- 11.16.7 SWOT Analysis
- 11.17 QT Ultrasound
- 11.17.1 Company Overview
- 11.17.2 Company Snapshot
- 11.17.3 Business Segments
- 11.17.4 Business Performance
- 11.17.5 Product Offerings
- 11.17.6 Key Developmental Strategies
- 11.17.7 SWOT Analysis
- 11.18 KUB Technologies
- 11.18.1 Company Overview
- 11.18.2 Company Snapshot
- 11.18.3 Business Segments
- 11.18.4 Business Performance
- 11.18.5 Product Offerings
- 11.18.6 Key Developmental Strategies
- 11.18.7 SWOT Analysis
- 11.19 Dilon Technologies
- 11.19.1 Company Overview
- 11.19.2 Company Snapshot
- 11.19.3 Business Segments
- 11.19.4 Business Performance
- 11.19.5 Product Offerings
- 11.19.6 Key Developmental Strategies
- 11.19.7 SWOT Analysis
- 11.20 Micrima
- 11.20.1 Company Overview
- 11.20.2 Company Snapshot
- 11.20.3 Business Segments
- 11.20.4 Business Performance
- 11.20.5 Product Offerings
- 11.20.6 Key Developmental Strategies
- 11.20.7 SWOT Analysis
- 11.21 CureMetrix
- 11.21.1 Company Overview
- 11.21.2 Company Snapshot
- 11.21.3 Business Segments
- 11.21.4 Business Performance
- 11.21.5 Product Offerings
- 11.21.6 Key Developmental Strategies
- 11.21.7 SWOT Analysis
- 11.22 iCAD
- 11.22.1 Company Overview
- 11.22.2 Company Snapshot
- 11.22.3 Business Segments
- 11.22.4 Business Performance
- 11.22.5 Product Offerings
- 11.22.6 Key Developmental Strategies
- 11.22.7 SWOT Analysis
- 11.23 ScreenPoint Medical
- 11.23.1 Company Overview
- 11.23.2 Company Snapshot
- 11.23.3 Business Segments
- 11.23.4 Business Performance
- 11.23.5 Product Offerings
- 11.23.6 Key Developmental Strategies
- 11.23.7 SWOT Analysis
- 11.24 Seno Medical Instruments
- 11.24.1 Company Overview
- 11.24.2 Company Snapshot
- 11.24.3 Business Segments
- 11.24.4 Business Performance
- 11.24.5 Product Offerings
- 11.24.6 Key Developmental Strategies
- 11.24.7 SWOT Analysis
- 11.25 Zebra Medical Vision
- 11.25.1 Company Overview
- 11.25.2 Company Snapshot
- 11.25.3 Business Segments
- 11.25.4 Business Performance
- 11.25.5 Product Offerings
- 11.25.6 Key Developmental Strategies
- 11.25.7 SWOT Analysis
- 11.26 Therapixel
- 11.26.1 Company Overview
- 11.26.2 Company Snapshot
- 11.26.3 Business Segments
- 11.26.4 Business Performance
- 11.26.5 Product Offerings
- 11.26.6 Key Developmental Strategies
- 11.26.7 SWOT Analysis
- 11.27 Metis Health Analytics
- 11.27.1 Company Overview
- 11.27.2 Company Snapshot
- 11.27.3 Business Segments
- 11.27.4 Business Performance
- 11.27.5 Product Offerings
- 11.27.6 Key Developmental Strategies
- 11.27.7 SWOT Analysis
- 11.28 Imago Systems
- 11.28.1 Company Overview
- 11.28.2 Company Snapshot
- 11.28.3 Business Segments
- 11.28.4 Business Performance
- 11.28.5 Product Offerings
- 11.28.6 Key Developmental Strategies
- 11.28.7 SWOT Analysis
- 11.29 Volpara Health
- 11.29.1 Company Overview
- 11.29.2 Company Snapshot
- 11.29.3 Business Segments
- 11.29.4 Business Performance
- 11.29.5 Product Offerings
- 11.29.6 Key Developmental Strategies
- 11.29.7 SWOT Analysis
- 11.30 Three Palm Software
- 11.30.1 Company Overview
- 11.30.2 Company Snapshot
- 11.30.3 Business Segments
- 11.30.4 Business Performance
- 11.30.5 Product Offerings
- 11.30.6 Key Developmental Strategies
- 11.30.7 SWOT Analysis
- 11.31 QView Medical
- 11.31.1 Company Overview
- 11.31.2 Company Snapshot
- 11.31.3 Business Segments
- 11.31.4 Business Performance
- 11.31.5 Product Offerings
- 11.31.6 Key Developmental Strategies
- 11.31.7 SWOT Analysis
- 11.32 NueMD
- 11.32.1 Company Overview
- 11.32.2 Company Snapshot
- 11.32.3 Business Segments
- 11.32.4 Business Performance
- 11.32.5 Product Offerings
- 11.32.6 Key Developmental Strategies
- 11.32.7 SWOT Analysis
- 11.33 Candelis
- 11.33.1 Company Overview
- 11.33.2 Company Snapshot
- 11.33.3 Business Segments
- 11.33.4 Business Performance
- 11.33.5 Product Offerings
- 11.33.6 Key Developmental Strategies
- 11.33.7 SWOT Analysis
- 11.34 Xoran Technologies
- 11.34.1 Company Overview
- 11.34.2 Company Snapshot
- 11.34.3 Business Segments
- 11.34.4 Business Performance
- 11.34.5 Product Offerings
- 11.34.6 Key Developmental Strategies
- 11.34.7 SWOT Analysis
- 11.35 DR Systems
- 11.35.1 Company Overview
- 11.35.2 Company Snapshot
- 11.35.3 Business Segments
- 11.35.4 Business Performance
- 11.35.5 Product Offerings
- 11.35.6 Key Developmental Strategies
- 11.35.7 SWOT Analysis
- 11.36 TeraRecon
- 11.36.1 Company Overview
- 11.36.2 Company Snapshot
- 11.36.3 Business Segments
- 11.36.4 Business Performance
- 11.36.5 Product Offerings
- 11.36.6 Key Developmental Strategies
- 11.36.7 SWOT Analysis
- 11.37 Median Technologies
- 11.37.1 Company Overview
- 11.37.2 Company Snapshot
- 11.37.3 Business Segments
- 11.37.4 Business Performance
- 11.37.5 Product Offerings
- 11.37.6 Key Developmental Strategies
- 11.37.7 SWOT Analysis
- 11.38 Medsight Technologies
- 11.38.1 Company Overview
- 11.38.2 Company Snapshot
- 11.38.3 Business Segments
- 11.38.4 Business Performance
- 11.38.5 Product Offerings
- 11.38.6 Key Developmental Strategies
- 11.38.7 SWOT Analysis
- 11.39 VuComp
- 11.39.1 Company Overview
- 11.39.2 Company Snapshot
- 11.39.3 Business Segments
- 11.39.4 Business Performance
- 11.39.5 Product Offerings
- 11.39.6 Key Developmental Strategies
- 11.39.7 SWOT Analysis
- 11.40 ClariPi
- 11.40.1 Company Overview
- 11.40.2 Company Snapshot
- 11.40.3 Business Segments
- 11.40.4 Business Performance
- 11.40.5 Product Offerings
- 11.40.6 Key Developmental Strategies
- 11.40.7 SWOT Analysis
- 11.2 Asia-Pacific
- 11.2.1 China
- 11.2.1.1 Key Market Trends & Opportunity Analysis
- 11.2.1.2 Market Size and Forecast
- 11.2.2 India
- 11.2.2.1 Key Market Trends & Opportunity Analysis
- 11.2.2.2 Market Size and Forecast
- 11.2.3 Japan
- 11.2.3.1 Key Market Trends & Opportunity Analysis
- 11.2.3.2 Market Size and Forecast
- 11.2.4 South Korea
- 11.2.4.1 Key Market Trends & Opportunity Analysis
- 11.2.4.2 Market Size and Forecast
- 11.2.5 Australia
- 11.2.5.1 Key Market Trends & Opportunity Analysis
- 11.2.5.2 Market Size and Forecast
- 11.2.6 Singapore
- 11.2.6.1 Key Market Trends & Opportunity Analysis
- 11.2.6.2 Market Size and Forecast
- 11.2.7 Indonesia
- 11.2.7.1 Key Market Trends & Opportunity Analysis
- 11.2.7.2 Market Size and Forecast
- 11.2.8 Taiwan
- 11.2.8.1 Key Market Trends & Opportunity Analysis
- 11.2.8.2 Market Size and Forecast
- 11.2.9 Malaysia
- 11.2.9.1 Key Market Trends & Opportunity Analysis
- 11.2.9.2 Market Size and Forecast
- 11.2.10 Thailand
- 11.2.10.1 Key Market Trends & Opportunity Analysis
- 11.2.10.2 Market Size and Forecast
- 11.2.11 Philippines
- 11.2.11.1 Key Market Trends & Opportunity Analysis
- 11.2.11.2 Market Size and Forecast
- 11.2.12 Vietnam
- 11.2.12.1 Key Market Trends & Opportunity Analysis
- 11.2.12.2 Market Size and Forecast
- 11.2.13 Rest of Asia-Pacific
- 11.2.13.1 Key Market Trends & Opportunity Analysis
- 11.2.13.2 Market Size and Forecast
- Chapter 12: Competitive Landscape
- 12.1 Overview
- 12.2 Market Share Analysis
- 12.3 Key Player Positioning
- 12.4 Competitive Leadership Mapping
- 12.4.1 Star Players
- 12.4.2 Innovators
- 12.4.3 Emerging Players
- 12.5 Vendor Benchmarking
- 12.6 Developmental Strategy Benchmarking
- 12.6.1 New Product Developments
- 12.6.2 Product Launches
- 12.6.3 Business Expansions
- 12.6.4 Partnerships, Joint Ventures, and Collaborations
- 12.6.5 Mergers and Acquisitions
- Chapter 13: Company Profiles
- 13.1 Hologic
- 13.1.1 Company Overview
- 13.1.2 Company Snapshot
- 13.1.3 Business Segments
- 13.1.4 Business Performance
- 13.1.5 Product Offerings
- 13.1.6 Key Developmental Strategies
- 13.1.7 SWOT Analysis
- 13.2 GE Healthcare
- 13.2.1 Company Overview
- 13.2.2 Company Snapshot
- 13.2.3 Business Segments
- 13.2.4 Business Performance
- 13.2.5 Product Offerings
- 13.2.6 Key Developmental Strategies
- 13.2.7 SWOT Analysis
- 13.3 Siemens Healthineers
- 13.3.1 Company Overview
- 13.3.2 Company Snapshot
- 13.3.3 Business Segments
- 13.3.4 Business Performance
- 13.3.5 Product Offerings
- 13.3.6 Key Developmental Strategies
- 13.3.7 SWOT Analysis
- 13.4 Fujifilm Holdings
- 13.4.1 Company Overview
- 13.4.2 Company Snapshot
- 13.4.3 Business Segments
- 13.4.4 Business Performance
- 13.4.5 Product Offerings
- 13.4.6 Key Developmental Strategies
- 13.4.7 SWOT Analysis
- 13.5 Philips Healthcare
- 13.5.1 Company Overview
- 13.5.2 Company Snapshot
- 13.5.3 Business Segments
- 13.5.4 Business Performance
- 13.5.5 Product Offerings
- 13.5.6 Key Developmental Strategies
- 13.5.7 SWOT Analysis
- 13.6 Canon Medical Systems
- 13.6.1 Company Overview
- 13.6.2 Company Snapshot
- 13.6.3 Business Segments
- 13.6.4 Business Performance
- 13.6.5 Product Offerings
- 13.6.6 Key Developmental Strategies
- 13.6.7 SWOT Analysis
- 13.7 Carestream Health
- 13.7.1 Company Overview
- 13.7.2 Company Snapshot
- 13.7.3 Business Segments
- 13.7.4 Business Performance
- 13.7.5 Product Offerings
- 13.7.6 Key Developmental Strategies
- 13.7.7 SWOT Analysis
- 13.8 Hitachi Medical Systems
- 13.8.1 Company Overview
- 13.8.2 Company Snapshot
- 13.8.3 Business Segments
- 13.8.4 Business Performance
- 13.8.5 Product Offerings
- 13.8.6 Key Developmental Strategies
- 13.8.7 SWOT Analysis
- 13.9 Planmed
- 13.9.1 Company Overview
- 13.9.2 Company Snapshot
- 13.9.3 Business Segments
- 13.9.4 Business Performance
- 13.9.5 Product Offerings
- 13.9.6 Key Developmental Strategies
- 13.9.7 SWOT Analysis
- 13.10 Toshiba Medical Systems
- 13.10.1 Company Overview
- 13.10.2 Company Snapshot
- 13.10.3 Business Segments
- 13.10.4 Business Performance
- 13.10.5 Product Offerings
- 13.10.6 Key Developmental Strategies
- 13.10.7 SWOT Analysis
- 13.11 Konica Minolta
- 13.11.1 Company Overview
- 13.11.2 Company Snapshot
- 13.11.3 Business Segments
- 13.11.4 Business Performance
- 13.11.5 Product Offerings
- 13.11.6 Key Developmental Strategies
- 13.11.7 SWOT Analysis
- 13.12 Agfa-Gevaert
- 13.12.1 Company Overview
- 13.12.2 Company Snapshot
- 13.12.3 Business Segments
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.